Drug-Price Policy Discussions Are Focus Of MedPAC, Pew, Oncologists

Congressional Medicare advisers are scheduled Thursday (April 7) to take up draft recommendations on policy changes to drug reimbursement in both Medicare Part D and Part B, and they’ll discuss policies that change how cancer doctors are paid for the drugs they administer. A few days later, Pew will host an event on CMS’ proposed Medicare Part B drug payment demonstration that has oncologists and drug makers up in arms. Community oncologists this week presented HHS officials with a study...